Form 4: Gilead Sciences Executive Deborah H. Telman Reports Stock Transactions
SEC Form 4 Filing
EVP Deborah H. Telman of Gilead Sciences reports the vesting and subsequent disposal of restricted stock units.
Summary
- On June 10, 2024, Deborah H. Telman, EVP, Corporate Affairs & GC of Gilead Sciences, Inc., reported transactions involving Gilead Sciences common stock.
- Telman disposed of 204 shares of common stock at a price of $65.25 per share to cover tax obligations.
- She also acquired 638 shares through the vesting of restricted stock units.
- Following these transactions, Telman directly owns 14,548 shares of Gilead Sciences common stock.
- She also directly owns 38,930 restricted stock units.
Sentiment
Score: 5
Explanation: Neutral sentiment as the document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC for corporate insiders, providing transparency into their trading activities and potential alignment with company performance.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of stock transactions (vesting of restricted stock units and disposal of shares). |
| 06/11/2024 | Date of report signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.